Advos

A new doctoral study from Karolinska Institutet finds that young adults often suffer sexual problems after cancer treatment, with severity varying by cancer type and treatment intensity, highlighting the need for better-tolerated therapies.

Child safety advocates are urging U.S. authorities to investigate Roblox over allegations of inadequate protections for young users against harmful content and aggressive monetization.

RiskFootprint™ has integrated Microsoft Copilot to deliver instant, defensible hazard and climate summaries from its reports, accelerating decision-making for real estate and lending professionals.

H2APEX Group SCA posted a 67% revenue increase to EUR 3.5 million in Q1 2026, driven by a new PMC contract and hydrogen sales, and reaffirmed its 2026 revenue target of EUR 14-16 million.

The Supervisory Board of Amadeus Fire Group early renewed COO Dennis Gerlitzki's contract through 2031, citing his crucial role amid German economic challenges.

R. STAHL AG announces the resignation of Management Board Chairman Dr. Claus Bischoff for personal reasons, effective May 31, 2026, with Tobias Popp assuming his responsibilities and the NEXUS programme continuing.

Limelight Software's 2026 FP&A Statistics Report finds that despite record technology spending and AI adoption set to more than double, nearly all finance professionals still rely on spreadsheets, and 61% of CFOs cite inaccurate forecasting as their top cost-control problem.

Adults with high heart health scores were nearly half as likely to be hospitalized or die from COVID-19, according to research published in the Journal of the American Heart Association.

Affluence Corporation announced a letter of intent to acquire Triar Commerce LLC, potentially boosting pro forma annualized revenue to $220 million, but the deal faces financing and due diligence hurdles.

GrocerIQ Holdings announces the initial rollout of AI-driven neighborhood grocery stores across Los Angeles, aiming to improve local access to essentials through smaller-format retail environments powered by proprietary physical AI technology.

tZERO Group's subsidiary VerifyInvestor.com has integrated its accredited investor verification services into the PandoAlts Market Checks platform, aiming to streamline onboarding and compliance for private market and alternative investments.

GeoVax Labs CEO David Dodd will present on building a resilient infectious disease strategy using MVA-based vaccine technologies in a May 28 webinar, highlighting the need to move beyond single-threat approaches amid recent outbreaks.

TransCode Therapeutics has launched a Phase 2a clinical trial of its lead candidate TTX-MC138 in colorectal cancer patients with minimal residual disease, aiming to reduce recurrence risk in a high-risk population.

Tonix Pharmaceuticals announced publication of positive Phase 1 data for its anti-CD40L monoclonal antibody TNX-1500, showing favorable safety and tolerability in healthy volunteers, supporting a planned Phase 2 kidney transplant rejection study in 2026.